CD4CAR for CD4+ Leukemia and Lymphoma
CD4CAR for CD4+ Leukemia and Lymphoma
Recruiting · NCT03829540 · Registry updated 2026-06-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD4CAR for CD4+ Leukemia and Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell leukemia, T-cell non-Hodgkin lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-06-24 | NCT03829540 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Huda Salman | 1 |
| iCell Gene Therapeutics | 7 |
| National Institutes of Health (NIH) | 667 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Albert Einstein Health Network | New York | United States | 1 |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | United States | 38 |
| Riley Hospital for Children | Indianapolis | United States | 134 |
| Stony Brook Cancer Center | Stony Brook | United States | 11 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| University of Miami Sylvester Comprehensive Cancer Center | Miami | United States | 18 |